MRK Jun 2024 130.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

20.95

0.00

(0.00%)

As of 12:51PM EST. Market open.

Simply Wall St.
Merck (NYSE:MRK) Has Announced That It Will Be Increasing Its Dividend To $0.73
Merck & Co., Inc. ( NYSE:MRK ) will increase its dividend from last year's comparable payment on the 10th of April to...
Business Wire
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
RAHWAY, N.J., January 27, 2023--FDA Approves KEYTRUDA as Adjuvant Treatment Following Surgical Resection and Chemotherapy for Patients With Stage IB (T2a ≥4 cm), II, or IIIA NSCLC
Zacks
Merck (MRK) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Merck (MRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.